• TRK Fusion + Cancers – Fullerton, CA

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • axSpA GR – Silver Spring, MD

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • Hemophilia A – New Orleans, LA

    Louisiana Center for Bleeding & Clotting 2000 Canal St, New Orleans, LA, United States

    This case-based live activity will cover the treatment and management of patients with hemophilia A

  • Hemophilia A – Brooklyn, NY

    The Brooklyn Hospital Center 121 DeKalb Avenue, Brooklyn, NY, United States

    This case-based live activity will cover the treatment and management of patients with hemophilia A

  • axSpA GR – Vincennes, ID

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • TRK Fusion + Cancers – Prescott, AZ

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • axSpA GR – Vincennes, ID

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • Hemophilia A – Brandon, FL

    This case-based live activity will cover the treatment and management of patients with hemophilia A

  • axSpA GR – Chicago, IL

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • aaxSpA GR – Chicago, IL

    This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

  • CRC Grand Rounds – St. Louis, MO

    This live activity will cover the treatment and management of patients with refractory metastatic colorectal cancer (CRC).